Eureka Forbes Ltd (EUREKAFORB) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company delivered a strong performance in Q4, achieving a revenue growth of 11.6% year-on-year, driven by double-digit growth in the water purifier business and sustained momentum in emerging categories.
- For the full year FY26, the company recorded its second consecutive year of double-digit growth, with revenues increasing by 11.3%, indicating sustained business momentum despite a challenging macroeconomic environment.
- Profitability reached a new high, with the Q4 adjusted EBITDA margin hitting 13.2%, the highest ever recorded. This was achieved despite intensifying input cost inflation, showcasing the inherent strength of the business model.
- The company significantly strengthened its balance sheet, transitioning from a net debt position in June 2022 to a substantial net cash surplus of 443 crores, providing strategic flexibility for future growth, including potential inorganic opportunities.
- Strategic evolution from a single-category focus to a multi-category health and hygiene company is proving successful, with emerging categories like Robotics, Air Purifiers, and Water Softeners becoming meaningful contributors to overall growth.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.